Pan-cancer analysis confirms the prognostic and immunological effects of prostate tumor overexpressed-1 in human cancers.

Liu, Fashun; Li, Zhen; Wan, Songlin; Li, Yue; Ye, Zhenxiong; Li, Daojiang

Liu, Fashun; Li, Zhen; Wan, Songlin; Li, Yue; Ye, Zhenxiong; Li, Daojiang.

Afiliación

Liu F; Department of General Surgery, Yangpu Hospital, Tongji University School of Medicine, Shanghai 200090, People's Republic of China.
Li Z; Department of General Surgery, Yangpu Hospital, Tongji University School of Medicine, Shanghai 200090, People's Republic of China.
Wan S; Department of Colorectal and Anal Surgery, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430072, People's Republic of China.
Li Y; Department of Colorectal and Anal Surgery, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430072, People's Republic of China.
Ye Z; Department of General Surgery, Yangpu Hospital, Tongji University School of Medicine, Shanghai 200090, People's Republic of China.
Li D; Department of Colorectal and Anal Surgery, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430072, People's Republic of China.

Curr Cancer Drug Targets ; 2023 Mar 16.

Article en En | MEDLINE | ID: mdl-36927431

Palabras clave

Prostate tumor overexpressed-1; bioinformatics; cancer; cancer-associated fibroblasts.; immune infiltration; prognosis; tumor

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Curr Cancer Drug Targets Asunto de la revista: ANTINEOPLASICOS / NEOPLASIAS Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google